Try our Advanced Search for more refined results

Deals Rumor Mill: Amgen, Newfield, Verizon

By Karlee Weinmann (August 15, 2013, 3:55 PM EDT) -- Amgen Inc.'s $9.5 billion takeover of rival Onyx Pharmaceuticals Inc. is being held up as the two lock horns over access to data from an ongoing clinical trial of one of Onyx's showcase cancer treatments, Bloomberg reported on Thursday. The news comes after earlier reports indicated that the two were closing in on a $130-per-share deal, sweetened from a previously rejected Amgen approach. Onyx is apparently prepared to accept the consideration but does not want to preliminarily view data from the trial, which is currently underway, out of concern that it will slow down the drug's approval process....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!